TrialJournal of pediatric gastroenterology and nutrition2014

High- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitis.

Harland S Winter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.